1. Home
  2. TFSL vs IOVA Comparison

TFSL vs IOVA Comparison

Compare TFSL & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TFS Financial Corporation

TFSL

TFS Financial Corporation

HOLD

Current Price

$13.95

Market Cap

3.9B

Sector

Finance

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$2.15

Market Cap

968.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFSL
IOVA
Founded
1938
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
968.6M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
TFSL
IOVA
Price
$13.95
$2.15
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$10.36
AVG Volume (30 Days)
675.6K
9.8M
Earning Date
01-29-2026
11-06-2025
Dividend Yield
8.22%
N/A
EPS Growth
14.29
N/A
EPS
0.32
N/A
Revenue
$318,974,000.00
$250,425,000.00
Revenue This Year
$11.17
$60.94
Revenue Next Year
$4.08
$60.85
P/E Ratio
$42.94
N/A
Revenue Growth
4.70
175.62
52 Week Low
$11.29
$1.64
52 Week High
$14.73
$8.56

Technical Indicators

Market Signals
Indicator
TFSL
IOVA
Relative Strength Index (RSI) 51.97 44.43
Support Level $13.60 $2.18
Resistance Level $14.08 $2.32
Average True Range (ATR) 0.27 0.11
MACD -0.05 -0.02
Stochastic Oscillator 31.11 7.36

Price Performance

Historical Comparison
TFSL
IOVA

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: